The profile of acinic cell carcinoma after recognition of mammary analog secretory carcinoma

American Journal of Surgical Pathology

Volumn 36, Issue 3, 2012, Pages 343-350

  Chiosea, Simion I ^a   Griffith, Christopher ^a   Assaad, Adel ^b   Seethala, Raja R ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

acinic; ETV6; high grade transformation; mammary analog

Indexed keywords

REPRESSOR PROTEIN; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR ETV6; TUMOR MARKER;

ACINAR CELL CARCINOMA; ARTICLE; BREAST TUMOR; CANCER STAGING; CARCINOMA; CHEMISTRY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE TRANSLOCATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; SALIVARY GLAND TUMOR; SECRETORY VESICLE; SURVIVAL RATE; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE;

BREAST NEOPLASMS; CARCINOMA; CARCINOMA, ACINAR CELL; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS C-ETS; REPRESSOR PROTEINS; SALIVARY GLAND NEOPLASMS; SECRETORY VESICLES; SURVIVAL RATE; TIME FACTORS; TRANSLOCATION, GENETIC; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84857653982     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318242a5b0     Document Type: Article

References (23)

1. Brandwein-Gensler M, Hille J, Wang BY, et al. Low-grade salivary duct carcinoma: description of 16 cases. Am J Surg Pathol. 2004;28:1040-1044.
2. Buxton RW, Maxwell JH, French A. Surgical treatment of epithelial tumors of the parotid gland. Surg Gynecol Obstet. 1953;97:401.
3. Castle JT, Thompson LD, Frommelt RA, et al. Polymorphous low grade adenocarcinoma: a clinicopathologic study of 164 cases. Cancer. 1999;86:207-219.
4. Chenevert J, Barnes LE, Chiosea SI. Mucoepidermoid carcinoma: a five-decade journey. Virchows Arch. 2011;458:133-140.
5. Chiosea SI, Peel R, Barnes EL, et al. Salivary type tumors seen in consultation. Virchows Arch. 2009;454:457-466.
6. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual. New York: Springer; 2010.
7. Ellis G, Simpson RHW. Acinic cell carcinoma. In: Barnes EL, Eveson JW, Reichart P, et al, eds. World Health Organization Classification of Tumors Pathology and Genetics Head and Neck Tumors. Lyons, France: IARC Press; 2005:216-218.
8. Ellis GL, Corio RL. Acinic cell adenocarcinoma. A clinicopathologic analysis of 294 cases. Cancer. 1983;52:542-549.
9. Gomez DR, Katabi N, Zhung J, et al. Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland. Cancer. 2009;115:2128-2137.
10. Griffith C, Seethala R, Chiosea SI. Mammary analogue secretory carcinoma: a new twist to the diagnostic dilemma of zymogen granule poor acinic cell carcinoma. Virchows Arch. 2011;459:117-118.
11. Hirokawa M, Sugihara K, Sai T, et al. Secretory carcinoma of the breast: a tumour analogous to salivary gland acinic cell carcinoma? Histopathology. 2002;40:223-229.
12. Lewis JE, Olsen KD, Weiland LH. Acinic cell carcinoma. Clinicopathologic review. Cancer. 1991;67:172-179.
13. Michal M, Skalova A, Simpson RH, et al. Well-differentiated acinic cell carcinoma of salivary glands associated with lymphoid stroma. Human Pathol. 1997;28:595-600.
14. Nasse D. Die Geschwülste der Speicheldrülen und verwandte Tumoren des Kopfes. Arch Klin Chir. 1892;44:233-302.
15. Reis-Filho JS, Natrajan R, Vatcheva R, et al. Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6 'split apart' probes. Histopathology. 2008;52:840-846.
16. Seethala RR, Barnes EL, Hunt JL. Epithelial-myoepithelial carcinoma: a review of the clinicopathologic spectrum and immunophenotypic characteristics in 61 tumors of the salivary glands and upper aerodigestive tract. Am J Surg Pathol. 2007;31:44-57.
17. Skalova A, Leivo I, Von Boguslawsky K, et al. Cell proliferation correlates with prognosis in acinic cell carcinomas of salivary gland origin. Immunohistochemical study of 30 cases using the MIB 1 antibody in formalin-fixed paraffin sections. J Pathol. 1994;173:13-21.
18. Skalova A, Sima R, Kaspirkova-Nemcova J, et al. Cribriform adenocarcinoma of minor salivary gland origin principally affecting the tongue: characterization of new entity. Am J Surg Pathol. 2011;35:1168-1176.
19. Skalova A, Sima R, Vanecek T, et al. Acinic cell carcinoma with high-grade transformation: a report of 9 cases with immunohistochemical study and analysis of TP53 and HER-2/neu genes. Am J Surg Pathol. 2009;33:1137-1145.
20. Skalova A, Vanecek T, Sima R, et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol. 2010;34:599-608.
21. Stanley RJ, Weiland LH, Olsen KD, et al. Dedifferentiated acinic cell (acinous) carcinoma of the parotid gland. Otolaryngol Head Neck Surg. 1988;98:155-161.
22. Timon CI, Dardick I, Panzarella T, et al. Clinico-pathological predictors of recurrence for acinic cell carcinoma. Clin Otolaryngol Allied Sci. 1995;20:396-401.
23. Watson MA, Darrow C, Zimonjic DB, et al. Structure and transcriptional regulation of the human mammaglobin gene, a breast cancer associated member of the uteroglobin gene family localized to chromosome 11q13. Oncogene. 1998;16:817-824.